The study was designed to validate in vivo a new method to measure ejection intraventricular pressure gradients (IVPGs) by processing color M-mode Doppler data and to assess the effects of inotropic interventions on IVPGs in the clinical setting. BACKGROUND In the absence of obstruction, ejection IVPGs cannot be estimated by Doppler using the simplified Bernoulli equation.
Regional ejection intraventricular pressure gradients (IVPGs) (representing the pressure field variation per unit of distance) are present within normal left ventricles (LVs), even in the absence of any anatomical obstruction (1) (2) (3) (4) . Consequently, physiological pressure differences (⌬Ps) in the range of 5 to 10 mm Hg have been measured between the LV apex and the left ventricular outflow tract (LVOT) using high-fidelity micromanometers (1, 4) . Ejection IVPGs arise from the unsteady nature of ejective flow, from chamber geometry, and from the sequence of regional contraction (3) . Therefore, ejection ⌬Ps are known to be related to the inotropic state and to LV size (2) .
Analysis of IVPGs is of particular interest in the clinical setting. Invasive studies have demonstrated that ejection IVPGs are responsible for a significant component of systolic afterload (3) . Also, IVPGs are known to be modified by myocardial diseases (5) , and the analysis of ejection IVPGs has proved to be useful in characterizing ventricular performance (3, 5) . However, the need for sophisticated catheterization procedures has limited further research into this field.
The simplified Bernoulli equation is an accurate method to calculate intracardiac ⌬Ps from Doppler-derived flowvelocity measurements, but is unsuitable in the absence of a restrictive orifice (6) . Ejection IVPGs are mainly inertial in origin (3), and they cannot be estimated using a formula that neglects local acceleration. Recently, we and other investigators (7) (8) (9) (10) have demonstrated that the Euler equation can be solved from color M-mode Doppler velocity data. The present study was designed with a twofold purpose: 1) in vivo validating, against high-fidelity pressure catheters, of a new noninvasive method to measure ejection IVPGs, and 2) testing the clinical applicability of the method to evaluate the effects of drug interventions on IVPGs in healthy volunteers and in patients with dilated cardiomyopathy (DCM).
METHODS
Animal experimental protocol. The animal study protocol was approved by the local Institutional Animal Care Committee. Eight minipigs (43 Ϯ 7 kg) were used in an open-chest instrumentation setup. Animals were preanes-thetized with ketamine and xylazine, and then mechanically ventilated. Complete anesthesia and relaxation during the experiment were obtained by repetitive boluses of pentobarbital (15 mg/kg intravenous ϩ 5 mg/kg/15 min) and pancuronium (0.2 mg/kg). Blood gases were measured at 15-to 30-min intervals, and the ventilator was adjusted accordingly. Once experiments were completed, animals either were euthanized or underwent subsequent unrelated experimental procedures.
The heart was exposed by median sternotomy without opening the pericardium and cradled to obtain a suitable ultrasonic window. For load manipulation, a snare was placed around the inferior vena cava, and a 20-mm valvuloplasty balloon was advanced to the infrarenal aorta. A pacing electrode was sutured to the right atrial appendage, and a needle micromanometer (Millar Instruments, Houston, Texas) was inserted epicardially inside the apex. A dual-micromanometer catheter (3-cm sensor spacing, Millar Instruments) was inserted retrogradely into the LV from the ascending aorta, placing the proximal sensor at the LVOT and the distal sensor in the mid-cavity. Micromanometers were prepared, balanced, and calibrated according to the manufacturer's specifications. To avoid drift and eliminate hydrostatic ⌬Ps (3), micromanometers were also balanced in vivo during a long diastasis following a premature beat. To ensure temporal matching of Dopplerechocardiography and pressure data, a synchronicity signal was simultaneously connected to the ultrasound scanner and the signal acquisition system. Pressure, synchronicity, and electrocardiographic (ECG) signals were digitized at 500 Hz on a Pentium III computer using custom-built amplifiers, a 16-channel A-D converter board (Keithley Instruments, Cleveland, Ohio), and virtual instrumentation software (Testpoint, Capital Equipment, Billerica, Massachusetts).
Each animal was studied at baseline and at four hemodynamic states: 1) esmolol (bolus 500 g/kg, followed by 50 to 200 g/kg/min in steps of 50 g/kg/min every 10 min); 2) dobutamine (up to 10 g/kg/min); and atrial pacing at: 3) 120 beats/min, and 4) 150 beats/min. In each state, data sets were acquired once hemodynamics were stable at baseline, during cava, and during aortic occlusion. Three consecutive beats were recorded during end-expiration apnea from each state-load condition. Human population and clinical protocol. Twenty healthy volunteers and 20 DCM patients were studied. Volunteers were not on any medication, and cardiovascular disease was ruled out by history, clinical examination, ECG, and Doppler-echocardiography. Inclusion criteria for DCM patients were: 1) ejection fraction Ͻ30%, 2) LV volumes Ͼ2 SD normal values for age and gender, and 3) sinus rhythm. Patients with a functional class IV or prior history of sustained ventricular tachycardia were not included. In volunteers, esmolol and dobutamine (same doses as in the animal protocol) were infused, followed by atropine (0.3-mg boluses) titrated to match dobutamine heart rate. Recordings were obtained during a steady hemodynamic state, and each drug was followed by a 30-min washout period. In DCM patients, only dobutamine was infused. The study protocol was approved by the institutional ethical committee, and written informed consent was obtained from all subjects. Echocardiographic image acquisition and analysis. A 2.0 to 3.5-MHz transducer was used on a Sequoia C-256 system (Siemens AG, Munich, Germany). Images were obtained from a posteriorly modified five-chamber apical view, using an epicardial (animals) and a transthoracic (humans) approach. Special care was taken to align the M-mode cursor with the ejective flow, visualized by twodimensional color Doppler. Horizontal sweep was set to 150 or 200 mm/s. End-diastolic and end-systolic dimensions, shortening fraction, and LV stroke volume were calculated in the clinical study from standard M-mode, twodimensional, and Doppler spectrograms as recommended (11) .
The general method used for digital image processing of color M-mode Doppler echocardiograms has been described elsewhere (10) . Briefly, if the M-mode cursor closely approximates a flow streamline, the spatio-temporal velocity distribution of a discrete blood sample is provided by the value of its corresponding pixel color: v(s,t), where v represents velocity, s represents the linear dimension of the streamline, and t is time. Thus, the color M-mode Doppler recording provides the data necessary to solve Euler's momentum equation:
where p designates pressure and represents blood density. The first term in the right side of the equation designates inertial (local) acceleration, whereas the second term accounts for convective (spatial) acceleration. Calibration and Doppler scale limits were automatically read from the image. The onset of the QRS was manually identified and defined as t ϭ 0. Velocity was decoded, dealiased, and fitted to a tensor-product smoothing spline (smoothing parameter p ϭ 0.004) (10) . Next, partial derivatives of the velocity data were calculated as the analytical first derivative of each polynomial piece. Ejection IVPGs were displayed as color overlays representing the ⌬P between one pixel and another one located 1 cm closer to the ultrasound transducer in mm Hg/cm (Fig. 1) . The locations of the LV apex and the LVOT were visually traced in the greyscale image layer, attempting to match instantaneous micromanometer positions (Fig. 1) . The distance between the mid-LV and LVOT micromanometers was measured from two-dimensional echocardiographic sequences obtained at the beginning of each acquisition (slightly less than nominal separation due to catheter bending, approximately 2.6 to 2.8 cm apart). Discrete ⌬Ps were calculated by spatial integration of IVPG maps between each pair of stations, providing three validation ⌬P curves from each IVPG image. In the clinical study, the apical-LVOT ⌬P was calculated. Intra-and interobserver reproducibility (30 beats from the clinical data set, blindly measured Ͼ3 months apart) of peak ejection ⌬P were 0.1 Ϯ 1.2 (R intraclass ϭ 0.93) and 0.2 Ϯ 1.0 mm Hg (R intraclass ϭ 0.95), respectively, where R intraclass represents the intraclass correlation coefficient. Pressure difference curve analysis. The ⌬P curves between apex-LVOT, apex-mid-cavity, and mid-cavity-LVOT were calculated offline by subtraction of the respective simultaneous pressure tracings. To ensure the analysis of the same beat, the temporal offset between Dopplerechocardiography and invasive data sets was obtained by cross-correlation of their synchronicity signals. The onset and the end of the ejection period were identified from the raw color-Doppler recordings as the beginning and the end of flow across the aortic valve. The following ⌬P parameters were blindly obtained for each technique, constrained to the ejection period: peak and time-to-peak, minimal and timeto-minimal, time to ⌬P inversion, and time to second inversion (slightly after end ejection). In the clinical study, both the value and the time of peak IVPG were also measured from the parametrical map. Temporal parameters were normalized to ejection duration in the clinical study. Statistical analysis. The validation analysis was performed on a single-beat basis, whereas results of three consecutive cycles were averaged in the clinical study. Quantitative variables are expressed as the mean Ϯ SD. The agreement between techniques was assessed calculating the mean Ϯ SD of error, Bland-Altman charts, and the intraclass correlation coefficient (R intraclass ). In the clinical study, differences among phases were assessed by analysis of variance accounting for repeated-measures, followed by Dunnet's contrasts. Unpaired t tests were used for comparisons between healthy volunteers and patients. Variables related to peak ⌬P were assessed calculating Pearson's correlation coefficients, followed by multivariate linear regression analysis with variable selection based on Alkaike's AIC criterion. A p value Ͻ0.05 was considered to be significant.
RESULTS

Experimental validation.
A total of 810 beats were analyzed. Peak baseline ejection ⌬Ps were 0.7 Ϯ 0.2, 2.5 Ϯ 1.5, and 2.9 Ϯ 1.7 mm Hg, for the apex-mid-LV, mid-LV-LVOT, and apex-LVOT locations, respectively. The ⌬P curves obtained by Doppler-echocardiography closely matched invasive signals, and a low-pass filter effect was observed in noninvasive tracings (Fig. 1) . The accuracy of Dopplerechocardiography ⌬P curve parameters was excellent (Table 1, Fig. 2 ). Beat-to-beat variability (animal data set, baseline states of all phases, n ϭ 66, three consecutive beats) for peak ejection ⌬P values was 0.6 Ϯ 0.5 and 0.5 Ϯ 0.5 mm Hg, for Doppler-echocardiography and micromanometer methods, respectively. The phase lag between methods was 7 Ϯ 25 ms. Ejection ⌬Ps adopted a characteristic configuration (Figs. 1  and 3) showing an early peak, a slow decrease, a mid-late ejection ⌬P reversal, and, finally, a late reverse peak. Ejection IVPGs were caused mainly by inertial forces, whereas convective ⌬P curves did not resemble micromanometer tracings (Fig. 3) . Pressure gradients in volunteers and DCM patients. There were no adverse drug effects, and recordings suitable for processing were obtained from all subjects. The highest IVPGs originated between the mid-cavity and the LVOT (Figs. 4 and 5 ). Patients showed a number of characteristics different from normal subjects: lower peak IVPG, lower peak ⌬P, and lower peak-reverse ⌬P values, mainly due to lower convective forces. The time to peak ⌬P and the time to ⌬P inversion occurred earlier during ejection in DCM patients than in normal subjects, whereas the time to second inversion occurred later. Dobutamine significantly increased all absolute values of IVPG and ⌬P. Conversely, peak positive values were decreased by esmolol in normal subjects. Atropine did not modify either IVPG or ⌬P parameters (Table 2) . Peak ⌬Ps correlated with heart rate, systolic blood pressure, and, most significantly, with stroke volume (Table 3) .
DISCUSSION
The present study demonstrates, for the first time in hearts without intraventricular obstruction, that ejection IVPGs can be accurately measured using Doppler-echocardiography. The clinical study illustrates the applicability of this technique and provides new spatio-temporal maps of the distribution of IVPG within the normal and DCM human ventricles.
Pressure gradients assessed by color M-mode Doppler.
The possibility of calculating intracardiac ⌬Ps from color M-mode Doppler images was first demonstrated by Greenberg et al. (7) . By solving the unsteady Bernoulli equation, these investigators accurately measured diastolic ⌬Ps across a normal mitral valve in an open-chest animal model (7), and in patients undergoing coronary artery bypass grafting (9) . Later, the same group validated a method for estimating diastolic intraventricular ⌬Ps, based on the solution of the Euler equation (8) . Our method, proposed almost simultaneously (10), introduces some potential improvements. First, velocity derivatives are solved analytically, increasing the robustness of mathematical calculations. Second, the effects of cardiac translation can be partially corrected by 
and 5).
A number of implicit assumptions are present in Euler's one-dimensional simplification of ejection flow-dynamics: 1) viscous frictional effects are neglible in the ejection field and confined to very thin boundary layers; 2) the main core of LV outflow is irrotational; and 3) there is an absence of vorticity in the LV ejection flow. These mechanical aspects of ventricular ejection, to date incompletely addressed in vivo (12) , are supported by our validation results. Methods based on solving fluid-dynamic differential equations, such as the one we propose, are accurate to calculate regional differences of pressure within and between the cardiac chambers. Absolute local pressure curves can only be inferred if instantaneous pressure at a given position is either known or assumed. Furthermore, to obtain absolute pressure from flow velocity accurately, not only local but also global inertial forces (those required to accelerate the total blood within the ventricle) would also have to be accounted for (5, 13) . Ejection IVPGs in health and disease. Laszt and Müller described the existence of ejection intraventricular regional ⌬Ps more than 50 years ago (14) . However, ejection ⌬Ps could not be well characterized until the introduction of high-fidelity solid-state pressure catheters (15) . With this tool, ejection intraventricular ⌬Ps were described in dogs, and the relationship with myocardial contractility was suggested (2). Also, intraventricular ejection ⌬Ps were studied invasively in a small number of normal subjects (1). Remarkably, both the magnitude and the shape of ⌬P curves obtained in our study are identical to the micromanometer tracings provided by these studies (1,3) . Although intraventricular ⌬Ps have never been analyzed in humans undergoing pharmacological interventions, our findings agree with previous invasive animal studies: peak ejection ⌬Ps are increased by beta-agonists (2, 16) , and reduced by betablocking agents (2, 16) .
Invasive assessment of intraventricular ⌬Ps has helped clarify the hemodynamics of obstructive and nonobstructive forms of hypertrophic cardiomyopathy (4). In aortic valve stenosis, ejection intraventricular ⌬Ps are responsible for about half the total transvalvular ⌬P, and they are a major determinant of cardiac output (17, 18) . However, to our knowledge, ejection intraventricular ⌬Ps have never been studied invasively in patients with DCM. Isaaz and Pasipoularides (5) used a noninvasive method to derive ejection ⌬Ps from manually digitized pulsed-wave Doppler spectrograms in patients with DCM. Their study also demonstrated that, although theoretically greater disproportion between the mid-LV and the LVOT should increase convective IVPGs in dilated ventricles (3), reduced ejection velocities due to systolic dysfunction cause convective forces to be lower than in normal hearts (5) . For this reason, the time to ⌬P reversal should take place earlier in DCM than in normal subjects. Our results in the DCM population are fully concordant with these observations (Table 2) . Clinical applications. The estimation of systolic IVPGs has important implications for the assessment of ventricular load. Our study validates a new noninvasive method to quantify intrinsic afterload (19) by Doppler-echocardiography. The results of our and previous studies (2, 5) indicate that the intrinsic load adds about 10% to the extrinsic load in normal subjects, a value that is close to the oscillatory component of aortic input impedance. Interestingly, the oscillatory component of longitudinal intraventricular systolic impedance can also be assessed using our method, and preliminary results suggest it might not be negligible (20) .
The use of the temporal derivative of LV pressure (dP/dt) as an index of myocardial contractility is based on the diagnostic value of initial impulsive forces (21) . A computer fluid-dynamic simulation has suggested a theoretical advantage of peak intraventricular ⌬P and flow acceleration over peak dP/dt (22) . Flow acceleration has recently been shown to provide a robust estimator of peak systolic elastance (23) . Similarly, the analysis of ejection IVPGs may be helpful to assess contractility (24) . Yotti et al. May 5, 2004 May 5, :1654 Ejection Pressure Gradients by Color Doppler
Reversed ⌬P during late ejection is the consequence of the kinetic energy of blood due to the momentum imparted to it earlier in systole (21, 25) . As shown in our study (Figs.  1, 3 , and 4), negative ejection gradients hold up to the isovolumic relaxation period. During isovolumic relaxation a negative (suction) ⌬P has been described between the LV apex and the LVOT (26) . Therefore, the temporal extent of diastolic-reversed IVPGs could be useful to determine the rate of myocardial relaxation (24) . Study limitations. Ejection velocities measured using Doppler represent the combination of intraventricular acceleration within the heart, plus the effect of ventricular translation within the chest. Because these two components are of opposite direction, Doppler-derived velocities are lower than net intraventricular velocities (27) . Although this would lead to underestimation of inertial acceleration, it has been recently demonstrated that longitudinal displacement of the center of mass of the LV is in the range of Ϯ5 cm/s (28) . Therefore, we believe this effect should not lead to significant inaccuracy either in open or in closed-chest setups.
A second potential limitation is that the validation study was not performed in humans, owing to the need of multisite micromanometer instrumentation. Because geometrical properties of the pig's LV closely resemble those of humans, we do not anticipate relevant species-related differences. A third limitation is related to LV outflow profile. In this study, outflow velocities were obtained across the center of the LVOT. However, it is known that outflow velocity is slightly skewed (29) . According to Euler's equation, regional variations in outflow profile should modify flow velocities and IVPGs in parallel. For this reason, special care was taken in the study to match micromanometer and echo-Doppler measuring stations. Nevertheless, the skewed outflow profile must be recognized as a source of limited consistency and reproducibility of all methods that measure ejection IVPGs. Finally, healthy volunteers and DCM patient groups were not matched for age; the comparison of hemodynamic findings between both groups should therefore be interpreted with caution. Conclusions. This study validates, for the first time, a fully noninvasive method to assess the dynamic interaction among myocardial performance, load mechanics, and intraventricular fluid dynamics in the clinical setting. Although the method is based on offline processing of digital color M-mode Doppler images, it could be incorporated into the analysis software of future ultrasound scanners. Pooled data from all inotropic states in 20 healthy volunteers and 20 dilated cardiomyopathy patients (n ϭ 120). b ϭ regression coefficient; ␤ ϭ standardized regression coefficient; LV ϭ left ventricular; R ϭ Pearson's correlation coefficient. Adjusted R 2 for the multivariate model ϭ 0.36.
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